Novel Compound from Datura innoxia Shows Promising Results Against Mycobacterium tuberculosis

Researchers from PMAS-Arid Agriculture University Rawalpindi have identified a potent phytocompound, o-vanillin, from the plant Datura innoxia that exhibits significant antitubercular activity against the Mycobacterium tuberculosis H37Ra strain. The study, published in Scientific Reports, highlights the compound's potential as a drug against tuberculosis (TB).

The researchers employed in vitro analysis to evaluate the activity of 20 phytocompounds from Datura innoxia, revealing that o-vanillin demonstrated the best minimal inhibitory concentration (MIC) of 12.5 μg/mL and minimal bactericidal concentration (MBC) of 50 μg/mL. The molecular docking and simulation also validated the strong affinity and stable binding interactions between the compound and target protein kinase. Furthermore, the pharmacokinetic analysis highlighted the compound's suitable oral bioavailability and lack of significant CYP450 inhibition, reducing the risk for drug-drug interactions.

Key Takeaways:

• The study identified o-vanillin, a phytocompound from Datura innoxia, as a potent inhibitor of Mycobacterium tuberculosis, with a MIC of 12.5 μg/mL and MBC of 50 μg/mL.
• The compound demonstrated strong affinity and stable binding interactions with target protein kinase, as validated by molecular docking and simulation.
• The pharmacokinetic analysis showed the compound's suitable oral bioavailability and lack of significant CYP450 inhibition.
• The results suggest that Datura innoxia contains the potent phytocompound o-vanillin, which possesses antitubercular activity and can potentially be used as a drug against TB.
• Future studies will focus on in vivo validation and formulation development for clinical applications.
• The study highlights the potential utility of Datura innoxia phytocompounds as a resource for the development of novel anti-TB drugs.

Statistics:

• The MIC of o-vanillin was 12.5 μg/mL.
• The MBC of o-vanillin was 50 μg/mL.
• The researchers evaluated 20 phytocompounds from Datura innoxia in the study.

Sources:

• In vitro investigation of Datura innoxia phytocompounds against Mycobacterium tuberculosis H37Ra strain in association with in silico studies. Scientific Reports, 2025, 15(1):1-16.
• The publisher for Scientific Reports is Nature Portfolio.
• The corresponding author for the study is Sajjad Ahmed Khan, University Institute of Biochemistry and Biotechnology, PMAS-Arid Agriculture University Rawalpindi.